Charles River Laboratories | Eiendeler



Assets Endring Dato
Agilent USD 11.91B 68M 2025-01
Align Technology USD 6.1B 111.78M 2025-03
Bio-Rad Laboratories USD 9.53B 162.8M 2025-03
Bruker USD 5.93B 122.7M 2025-03
Cardinal Health USD 49.87B 2.87B 2025-03
Charles River Laboratories USD 7.58B 54.02M 2025-03
Cigna USD 150.66B 5.22B 2025-03
CVS Health USD 255.58B 2.37B 2025-03
Danaher USD 79.12B 1.57B 2025-03
Dentsply International USD 5.75B 873M 2024-12
Elevance Health USD 119.72B 3.04B 2025-03
Galapagos EUR 4.02B 113.77M 2025-03
Hologic USD 8.55B 183.6M 2025-03
Humana USD 50.93B 4.45B 2025-03
Illumina USD 6.3B 289M 2024-12
Incyte USD 5.75B 305.04M 2025-03
IQVIA Holdings USD 27.32B 423M 2025-03
Laboratory Of America USD 17.6B 775.2M 2025-03
Lonza CHF 19.73B 1.85B 2024-12
McKesson USD 71.08B 1.35B 2024-12
Merck EUR 51.57B 1.42B 2024-12
Mettler Toledo International USD 3.23B 5.32M 2025-03
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
Quest Diagnostics USD 15.8B 356M 2025-03
Revvity USD 12.36B 31.75M 2025-03
Thermo Fisher Scientific USD 99.04B 1.72B 2025-03
United Therapeutics USD 7.74B 379.9M 2025-03
UnitedHealth USD 309.79B 11.51B 2025-03
Walgreens Boots Alliance USD 70.22B 8.32B 2025-02
Waters USD 4.59B 37.78M 2025-03
West Pharmaceutical Services USD 3.62B 25.2M 2025-03



Charles River Laboratories Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.